PALO ALTO and NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX and SCLXW), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), an ...

Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex Holding Company (SCLX) (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. (DECA) (Nasdaq: DECA, the “SPAC”) ...

LAS VEGAS--(BUSINESS WIRE)--Ault Global Holdings, Inc. (NYSE American: DPW), a diversified holding company (the “Company”), today published an unaudited update on Bitcoin production and miner ...

LAS VEGAS--(BUSINESS WIRE)--Ault Global Holdings, Inc. (NYSE American: DPW), a diversified holding company (the “Company”), is pleased to announce that its subsidiary, BitNile, Inc. (“BitNile”), will ...

PALO ALTO, Calif., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex”), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), today announced ...

Holding companies own subsidiaries but don't produce goods or services themselves. They offer legal liability protection, better financing terms, and tax consolidation advantages. Disadvantages ...

The removal of the Watch Developing Status and affirmation of the ratings are based on Prosperity’s experienced management team that is further enhanced with JAB Holding Company’s expert insurance ...

Crown European Holdings S.A., a wholly owned subsidiary of Crown Holdings, Inc. (NYSE:CCK), a $10.6 billion market cap company with strong financial health, completed the issuance of €500 million ...

The MCA has increased the financial limits for small companies, reducing compliance requirements while retaining key statutory obligations, enabling easier growth and operational ...

Semnur’s shares of common stock and warrants are expected to continue to trade on the OTC Markets under the ticker symbols “SMNR” and “SMNRW”, respectively. Scilex (SCLX) (together with its affiliates ...

Preliminary Q3 2020 net sales of ZTlido ® of approximately $7.2 million, quarter-over-quarter growth of 26% compared to $5.7MM in Q2-2020 despite the continued impact of COVID-19 pandemic. The Phase 3 ...